miscsubjectsAI governance
Evidence review

TB-500 for Skin: Evidence-Graded Look at Repair Pathways

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tb-500-skin`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tb-500-skin

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-skin/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-skin/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-skin/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-skin/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: TB-500 (thymosin beta-4) is studied for repair-cell migration and actin regulation — cells that need to reach an injury and rebuild structure. That is regeneration: move repair machinery to the damage.

Why TB-500 might help you

  1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • TB-500 → inflammation clearance / repair-cell migration

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.4 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Utilizing Developmentally Essential Secreted Peptides Such ... (source s0)

Summarizes Phase II dermal outcomes and safety.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

TB-500 for Injury Recovery (source s1)

Details Phase 1 human safety data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymosin Beta-4 and TB-500 in Tissue Healing ... (source s2)

2026 scoping review grading evidence distribution.

Evidence type: Published research.

Thymosin beta4 accelerates wound healing (source s23)

Original rat dermal wound study.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

What people say on Reddit

BPC-157 vs TB-500 — Reddit, r/USPeptides (source s19)

Reddit summary of rodent-to-user translation on skin.

Safety and limits

  1. Phase 1 study in 84 volunteers found recombinant thymosin beta-4 well tolerated with no serious adverse events.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Skin / collagen · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedTB-500: Thymosin Beta-4 · 14 humanAging Repair Stack: BPC-157 + TB-500 + GHK-Cu · 12 humanRecovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290 · 7 humanTB-500 for Benzodiazepine Withdrawal: Evidence-Graded Review · 2 human
Evidence · 5 sources · swipe →chain 7a1670c9ef58 · verify chain · provenance
1 / 5
Evidence ledger 5 · tier-ranked · API
human
Phase 1 study in 84 volunteers found recombinant thymosin beta-4 well tolerated with no serious adverse events.
sources: s1
human
Phase II dermal trials showed accelerated wound closure in pressure ulcers, stasis ulcers, and epidermolysis bullosa with TB4 described as safe.
sources: s0
preclinical
Rat full-thickness wound study (Malinda 1999) found Tβ4 increased re-epithelialization 42-61% versus control plus more angiogenesis.
sources: s23
anecdotallow confidence
Reddit users describe faster skin closure and improved skin quality after TB-500.
sources: s19
Low-confidence / auto-generated 1
speculative0.10low confidence
2026 scoping review states human TB4 evidence concentrates in wound/skin settings while overall literature is largely preclinical.
grok/grok-4.3
Grades the distribution of evidence tiers.
sources: s2
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:31
TB-500 for Skin: Evidence-Graded Look at Repair Pathways · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: TB 500 for Skin
Slug: tb-500-skin
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tb-500","name":"TB-500"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_layers":[],
it output
{
  "slug": "tb-500-skin",
  "title": "TB-500 for Skin: Evidence-Graded Look at Repair Pathways",
  "body": "## What's breaking down\n\nSkin repair stalls when repair cells cannot reach the injury site quickly enough. Inflammation lingers instead of clearing. Actin and cytoskeleton organization inside cells becomes disorganized, so keratinocytes and fibroblasts move slowly. New blood vessels form too late. Collagen deposition lags. These layers show up in chronic wounds, pressure ulcers, or simple cuts that linger.\n\nIf those steps slow, breakdown outruns repair. The skin stays open or thin longer than it should.\n\n## Why TB-500 might help you\n\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nIf your skin wounds show slow edge closure or poor new vessel growth, the same migration and actin-sequestering actions studied in thymosin beta-4 research are the ones people reference for this exact layer.\n\n## How these fit together\n\nSingle-compound focus. TB-500 maps to inflammation clearance / repa
dcf5deec876be8b8
Machine verification: /api/articles/tb-500-skin/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
AgentKit: a post-mortem in advanceposted 2026-07-24what-agentkit-wasA2A, from its own documentsposted 2026-07-24what-is-a2aMCP, from its own documentsposted 2026-07-24what-is-mcpLangChain, from its own documentsposted 2026-07-24what-is-langchainThe parts you can't buy yetposted 2026-07-24the-parts-you-cant-buy-yet

Related articles

Skin / collagen · condition map

Open evidence map →
Aging Repair Stack: BPC-157 + TB-500 + GHK-Cuaging-stack-introRecovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290recovery-stack-introTB-500: Thymosin Beta-4tb-500TB-500 for Benzodiazepine Withdrawal: Evidence-Graded Reviewtb-500-benzo-withdrawalTB-500 and Benzodiazepines: Repair Pathways vs GABA Suppressiontb-500-benzodiazepinesTB-500 and Statin-Associated Cognitive Effects: Repair Pathways and Ev…tb-500-brain-fog
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Phase 1 study in 84 volunteers found recombinant thymosin beta-4 well tolerated with no serious adverse events."?
ask tb-500-skin claim c5 · paste includes §SELF
What does the ledger say about this (human tier): "Phase II dermal trials showed accelerated wound closure in pressure ulcers, stasis ulcers, and epidermolysis bullosa with TB4 described as s…"?
ask tb-500-skin claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Rat full-thickness wound study (Malinda 1999) found Tβ4 increased re-epithelialization 42-61% versus control plus more angiogenesis."?
ask tb-500-skin claim c2 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users describe faster skin closure and improved skin quality after TB-500."?
ask tb-500-skin claim c4 · paste includes §SELF
What does the ledger say about this (speculative tier): "2026 scoping review states human TB4 evidence concentrates in wound/skin settings while overall literature is largely preclinical."?
ask tb-500-skin claim c3 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit summary of rodent-to-user translation on skin."
ask tb-500-skin source s19 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about TB-500 for Skin: Evidence-Graded Look at Repair Pathways — and what would you need me to tell you first?
ask tb-500-skin condition gaps · paste includes §SELF
What good and bad outcomes are documented for TB-500 for Skin: Evidence-Graded Look at Repair Pathways (studies vs anecdotes)?
ask tb-500-skin good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…